GALT CIK: 1133416

Galectin Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.3
FY22:
−31.1
FY23:
−33.0
FY24:
−41.8
FY25:
−23.9
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
36.8
FY22:
10.0
FY23:
40.0
FY24:
31.2
FY25:
26.5

All amounts in millions USD Data source:SEC EDGAR